Please try another search
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase – I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. In addition, its development pipeline includes cannabinoid derivative products comprising OCT960609, a dual CB1 and CB2 agonist targeting an undisclosed neuropathic pain indications; and immunotherapy agents for the treatment of solid tumours. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Julie Patricia Pomeroy | 67 | 2021 | Independent Non-Executive Chair |
Indraneil Mahapatra | 43 | 2021 | Co-Founder & Non-Executive Director |
Clarissa Ann Sowemimo-Coker | 42 | 2018 | CEO & Executive Director |
Paul William Smalley | 50 | 2022 | Finance Director & Executive Director |
Charanjit Dhillon | 64 | 2021 | Senior Independent Non-Executive Director |
Timothy H. Corn | 72 | 2023 | Executive Director & Chief Medical Officer |
Anthony Dickenson | - | 2022 | Member of Scientific Advisory Board |
. Mott | - | 2024 | Independent Non-Executive Director |
Robert H. Dworkin | - | 2022 | Member of Scientific Advisory Board |
Giorgio Lambru | - | 2022 | Member of Scientific Advisory Board |
William Paul Farquhar-Smith | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review